It was a fascinating CBSA BioBreakfast last week featuring two companies accelerating along the greatness trajectory, Accera Pharma and QLT, Inc (NASDAQ: QLTI). Today we will dig in first on QLT. QLT is a biopharmaceutical company engaged in the discovery, development, and commercialization of therapies in the fields of ophthalmology and dermatology. Its approved products [...]